Dr Suzy Dilly, CEO of ValiRx, discusses the amendment of the VAL201 license which will allow ValiRx and TheoremRx Inc. to proceed to full license without further CRT involvement.
Click here for the full BRR Media Video Update.
20 Dec 2021
Videos and audiocasts
Dr Suzy Dilly, CEO of ValiRx, discusses the amendment of the VAL201 license which will allow ValiRx and TheoremRx Inc. to proceed to full license without further CRT involvement.
Click here for the full BRR Media Video Update.